Menu

Three drugmakers recently asked a federal appeals court in Washington, D.C. to dismiss 340B Health's cross-appeal filed as part of ongoing 340B rebate litigation.

Drugmakers Urge Appeals Court to Toss Hospital Group’s Cross-Appeal in 340B Rebate Case

June 26, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Don’t Miss a Claim: How to Monitor Disqualified Claims in Your 340B Program

HRSA Issues New Health Center 340B Requirements for Insulin, EpiPens Following Trump’s April Executive Order